Newer strategies for the kala-azar elimination programme in India

Indian Journal of Medical Research

Volumn 129, Issue 1, 2009, Pages 102-104

  Thakur, C P ^a   Kumar, Amit ^a   Thakur, Meenakshi ^a   Thakur, Shabnam ^a  

^a Balaji Utthan Sansthan   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY GLUCONATE; CHLORPHENOTANE; DIAGNOSTIC AGENT; MILTEFOSINE; PAROMOMYCIN; RK 39; UNCLASSIFIED DRUG; UREA STIBAMINE;

CARDIOTOXICITY; CLINICAL PROTOCOL; DRUG EFFICACY; DRUG POTENCY; GASTROENTERITIS; HEALTH PROGRAM; HOUSING; HUMAN; INDIA; INFECTION CONTROL; LEISHMANIASIS; LETTER; MORTALITY; NEURITIS; RISK REDUCTION; RURAL HEALTH CARE; SKIN LEISHMANIASIS;

AMPHOTERICIN B; DATA COLLECTION; HUMANS; INDIA; INFORMATION DISSEMINATION; LEISHMANIASIS, VISCERAL; PHOSPHORYLCHOLINE; PRIMARY PREVENTION;

EID: 65949123139     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Letter

References (11)

1. Singh RP. Observation on dermal leishmaniasis in Bihar. Indian J Dermatol 1968; 3: 1-5.
2. Sanyal RK. Some observations on epidemiology of current outbreak of kala-azar in Bihar. J Commun Dis 1979; 4: 170-82.
3. Sengupta PC. Return of kala-azar. J Indian Med Assoc 1975; 65: 89-90.
4. Dutta M, Ghosh TK. Review of current status of leishmaniasis epidemiology. In: Mahajan RC, editor. Proceedings of the Indo-U.K. workshop on leishmaniasis. New Delhi: Indian Council of Medical Research; 1983. p. 97-102.
5. Peters W. The treatment of kala-azar - new approach to an old problem. Indian J Med Res 1981; 73 (Suppl): 1-18.
6. Government of India. Report of Expert Team on kala-azar programme assessment, New Delhi: Directorate of National Malaria Eradication Programme; 1991.
7. Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, et al. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 2000; 31: 1104-7.
8. National Health Policy 2002 Department of Health, Ministry of Health and Family Welfare, Government of India, New Delhi. Available at http:// mohfw.nic.in.
9. Thakur CP. A new strategy for elimination of kala-azar from rural Bihar. Indian J Med Res 2007; 126: 447-51.
10. Thakur CP, Kumar A, Mitra G, Thakur S, Sinha PK, Das P, et al. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Indian J Med Res 2008; 128: 38-44.
11. Shortt HE. Introduction: Indian Medical Research Memoirs no. 25, August 1932. p. 1-6. Reports of the kala-azar Commission, India. Report No II (1926-1930). Calcutta: Thacker, Spink & Co Ltd; 1932.